We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Ombudsman Clears EMA in Rejection of Over-the-Counter Migraine Drug
Ombudsman Clears EMA in Rejection of Over-the-Counter Migraine Drug
The European Medicines Agency acted properly in rejecting a UK-based pharmaceutical company’s over-the-counter migraine medicine, the European ombudsman says.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor